Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Evevogs-M 0.3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Eleveton Pharma

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview Evevogs-M 0.3 Tablet SR

Diabeva-M 0.3mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adult patients. It aids in regulating blood glucose levels. Diabeva-M 0.3mg Extended-Release tablets should be administered with food, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar or well-being. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as advised by your doctor. Lifestyle modifications significantly impact diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes. These are typically transient and self-limiting. Persistent or concerning side effects warrant medical attention. Your physician can address or manage troublesome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Evevogs-M 0.3 Tablet SR

There is no text provided to rephrase.

Uses of Evevogs-M 0.3 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Evevogs-M 0.3 Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Evevogs-M 0.3mg Extended-Release Tablet with food.

Common Side effects of Evevogs-M 0.3 Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Evevogs-M 0.3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Evevogs-M 0.3mg Extended-Release Tablet with food.

How Evevogs-M 0.3 Tablet SR works:

Evevogs-M 0.3mg Extended-Release tablet contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Evevogs-M 0.3 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Evevogs-M 0.3mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Evevogs-M 0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

The extended-release Evevogs-M 0.3mg tablet typically does not impair driving ability. Nevertheless, concurrent use with other antidiabetic medications, including sulfonylureas, insulin, and repaglinide, necessitates caution due to the potential for low blood sugar.

KidneyKidneyCAUTION

Patients with kidney impairment should use Evevogs-M 0.3 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the use of Evevogs-M 0.3 Tablet SR in individuals with hepatic impairment is scarce. Physician consultation is recommended.

What if you forget to take Evevogs-M 0.3 Tablet SR :

Should you forget a dose of Evevogs-M 0.3 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Evevogs-M 0.3 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management
Evevogs-M 0.3 Tablet SR
57
MRP 70
18% off